Basit öğe kaydını göster

COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population

dc.contributor.authorOyaci, Yasemin
dc.contributor.authorPehlivan, Sacide
dc.contributor.authorAydin, Pinar Cetinay
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorAytac, Hasan Mervan
dc.date.accessioned2022-02-18T10:08:39Z
dc.date.available2022-02-18T10:08:39Z
dc.date.issued2022
dc.identifier.citationAytac H. M. , Oyaci Y., Aydin P. C. , Pehlivan M., Pehlivan S., "COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population", NEUROSCIENCES, cilt.27, sa.1, ss.24-30, 2022
dc.identifier.issn1319-6138
dc.identifier.otherav_7ee6c8aa-6e61-4125-87ff-e2091748be46
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/178636
dc.identifier.urihttps://doi.org/10.17712/nsj.2022.1.20210045
dc.description.abstractObjectives: To investigate catechol-O-methyltransferase (COMT) Val158Met gene polymorphism in MDMA use disorder (MUD) by comparing genotype distributions between MUD patients and healthy controls considering clinical parameters.
dc.language.isoeng
dc.subjectNeurology (clinical)
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectNeurology
dc.subjectNöroloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleCOMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population
dc.typeMakale
dc.relation.journalNEUROSCIENCES
dc.contributor.departmentBasaksehir Cam & Sakura City Hosp , ,
dc.identifier.volume27
dc.identifier.issue1
dc.identifier.startpage24
dc.identifier.endpage30
dc.contributor.firstauthorID3134289


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster